Journal: Cancer Biology & Therapy
Article Title: FASN contributes to ADM resistance of diffuse large B-cell lymphoma by inhibiting ferroptosis via nf-κB/STAT3/GPX4 axis
doi: 10.1080/15384047.2024.2403197
Figure Lengend Snippet: FASN promoted tumor growth and resistance of DLBCL to ADM by inhibiting ferroptosis in vivo . The mice ( n = 6) were injected with FASN overexpressed or the control SU-DHL-2 cells subcutaneously to establish xenograft mice models. The mice were randomly divided into 4 groups, and were injected intraperitoneally with 2 mg/kg ADM twice a week or 20 mg/kg erastin every two days, as indicated by grouping. (a) The xenograft tumor tissues were isolated from the mice. (b) The weight and volume of the tumors were recorded and quantified. (c) The expression of GPX4, FASN, and 4-HNE in tumor tissues was validated by the IHC experiment. (d) The cell apoptosis of tumor tissues was detected by the TUNEL assay. Data from at least three repeated experiments. * p <.05, ** p <.01.
Article Snippet: The two DLBCL cell lines (SU-DHL-2 and U2932 cells) obtained from DSMZ (German Collection of Microorganisms and Cell Cultures) were cultured in RPMI-1640 medium (Tecno, Hangzhou, China, L121–500) with 10% FBS (SERANA, Brandenburg, Germany, S-FBS-SA-015) and 1% penicillin–streptomycin (Pen-Strep, Gibco, Semitic, NY, USA 15,140,122) added in a 5% CO 2 incubator at 37°C.
Techniques: In Vivo, Injection, Control, Isolation, Expressing, TUNEL Assay